Venture Life Group (LON:VLG) Stock Breaks Above Fifty Day Moving Average – Here’s What Happened

Venture Life Group plc (LON:VLG – Get Free Report) crossed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of GBX 67.40 and traded as high as GBX 69.50. Venture Life Group shares last traded at GBX 69.50, with a volume of 441,624 shares.

Venture Life Group Trading Up 0.9%

The business’s 50-day moving average is GBX 67.40 and its two-hundred day moving average is GBX 65.17. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.48 and a current ratio of 4.71. The stock has a market capitalization of £82.59 million, a PE ratio of 15.93, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23.

Venture Life Group (LON:VLG – Get Free Report) last announced its quarterly earnings data on Tuesday, September 29th. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Venture Life Group had a net margin of 17.42% and a return on equity of 7.82%. As a group, equities research analysts anticipate that Venture Life Group plc will post 6.14 earnings per share for the current year.

Insider Buying and Selling at Venture Life Group

In other news, insider Daniel Wells purchased 14,760 shares of the company’s stock in a transaction dated Thursday, October 1st. The shares were acquired at an average cost of GBX 68 per share, for a total transaction of £10,036.80. 7.65% of the stock is currently owned by insiders.

About Venture Life Group

(Get Free Report)

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.

Recommended Stories

Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.